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Abstract
Objective: This study aims to explore relationships between preferred and experienced
clinical decision making with service use, and associated costs, by people with severe mental illness.
Methods: Prospective observational study of mental healthcare in six European countries:
Germany, UK, Italy Hungary, Denmark and Switzerland. Patients (N = 588) and treating clinicians (N =
213) reported preferred and experienced decision making at baseline using the Clinical Decision
Making Style Scale (CDMS) and the Clinical Decision Involvement and Satisfaction Scale (CDIS).
Retrospective service use was assessed with the Client Socio-Demographic and Service Receipt
Inventory (CSSRI-EU) at baseline and 12-month follow-up. Negative binomial regression analyses
examined the effects of CDMS and CDIS on service use and inpatient costs at baseline and multilevel
models examined these relationships over time.
Results: At baseline, staff and patient preferences for active decision making and low patient
satisfaction with experienced decisions were associated with longer hospital admissions and higher
costs. Patient preferences for active decision making predicted increases in hospital admissions (b =
.236, p =.043) over 12 months and cost increases were predicted by low patient satisfaction (b = 4803,
p =.005). Decision making was unrelated to medication, outpatient, or community service use.
Conclusions: Decision making is related to inpatient service use and associated costs by
people with severe mental illness. A preference for shared decision making may reduce healthcare
costs via a reduction in inpatient admissions. Patient satisfaction with decisions is a crucial predictor of
healthcare costs; therefore, clinicians should maximize patient satisfaction with decision making.
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Introduction
There is widespread agreement that shared, rather than passive, clinical decision making
between patients and staff is an ethical obligation (1–3). A collaborative process of decision making
contributes to high-quality, patient-centered healthcare (4), with some evidence indicating that shared
decision making might have positive effects on treatment outcomes (1,5,6). There is also growing
evidence suggesting that, in medical settings, shared decision making may be associated with cost-
effectiveness (7), by reducing hospital admissions and other associated medical costs (8).
Although the extant body of literature exploring decision making has largely focused on
physical health conditions, decision making is a growing area of interest in psychiatric settings,
especially in the treatment of severe mental illness (9–11) with psychiatric patients shown to be
capable of (3) and expressing a preference for shared decision making (12–14,1,15). However it
remains largely unknown if a preference for or experiences of shared decision making impacts upon
service use. It has been suggested that higher involvement of mental health patients in decision
making might increase their engagement with services (16), although empirical evidence remains
equivocal (1). Likewise, some evidence indicates that satisfaction with decision making has a positive
relationship with medication adherence (17), yet other studies have found no such relationship (18).
Although there is limited evidence that shared decision making may reduce physical healthcare costs
through the reduction of utilizing ineffective or undesirable treatments (19), whether such cost-
effectiveness is seen in mental health care remains unknown.
Despite the potential links between decision making and service use and satisfaction with
services, research exploring decision making and its impact on adherence, engagement and service
use in mental health remains scant (20), especially in real world psychiatric settings (6). The extent to
which experiences of CDM and preferred CDM impact service use and the associated costs remains
largely unknown. Therefore, the current study aims to examine decision making in routine psychiatric
care for people with severe mental illness through an exploration of the relationship between preferred
and experienced CDM with service use. Specifically, this study examines the following questions: a)
Do CDM preferences regarding participation in decision making influence service use and costs? b)
Does preference for the level of information impact service use? c) Does experienced level of
involvement in decision making impact service use? d) Does satisfaction with experienced
clinical decisions impact service use?
Method
Design
The study was undertaken as part of the European multicenter study, “Clinical
decision making and outcome in routine care for people with severe mental illness” (CEDAR,
ISRCTN75841675) (21); a prospective observational study of routine psychiatric care. Patients
and staff were recruited from outpatient/community mental health services in six European
countries (Germany, UK, Italy, Hungary, Denmark, and Switzerland) between November 2009
and December 2010. Ethical approval was obtained from all participating centers. We used
CDM data collected at baseline and service use data that were collected at baseline and 12-
month follow up.
Participants
Participants who presented with any psychiatric diagnosis - established by case notes
or staff communication, based on SCID criteria (22,23) - were recruited from six European
centers. Inclusion criteria were (a) aged 18-60, (b) presence of severe mental illness
(Threshold Assessment Grid (24) ≥ 5 points and illness duration ≥ 2 year), (c) expected 
contact with mental health services for one year, (d) sufficient language proficiency, and (e)
capacity to provide informed consent. Exclusion criteria were (a) main diagnosis of learning
disability, dementia, substance misuse or organic brain disorder, (b) severe cognitive
impairment, or (c) treatment by forensic mental health services. At baseline, patients identified
a key professional involved in their care, who was then approached for study participation.
Patients and professionals who provided informed consent following an explanation of the
study protocol were included in the study (see Puschner et al. (21) for further information on
study procedures).
Measures
Client Sociodemographic and Service Use Inventory (CSSRI-EU). The CSSRI-EU (25)
provides self-report information in five areas: (a) sociodemographic data including ethnicity and
education level, (b) living situation, (c) employment and income, (d) service receipt such as inpatient
and outpatient hospital services, primary and secondary community care contacts, and (e) medication
use. For pragmatic reasons, the data on medication was assessed using a shortened version of the
CSSRI (Paul McCrone, personal communication), with patients being asked to indicate type
(psychotropic or non-psychotropic) and number of medications (while the original version also asks for
brand name and dose). Community and outpatient services for the prior three months, and number of
medications used in the previous one month, were collected. Number and duration of inpatient stays
was collected for the previous 12 months. Total costs of inpatient days were calculated by allocating
unit costs based on average costs per day of inpatient stays in each participating center during the
observation period.
Clinical Decision Making Style Scale (CDMS). The CDMS (27) measures preferences for
CDM. Identically structured parallel versions of the CDMS have been designed for staff and patients.
The CDMS is divided into three sections and yields two subscales: Participation in Decision Making
(PD) and Information (IN). PD is measured by two sections: a) agreement on a 5-point Likert scale
with six items such as “important decisions should be made by the clinician in charge and not by me”
and b) ratings on nine items regarding if the decision should be made by the clinician, patient or
shared, based on three vignettes in the areas of work, medication and side effects. The PD subscale
score is then classified into one of three categories: a preference for active, shared, or passive
decision making. The IN subscale is measured by agreement on a 5-point Likert scale with six items
regarding the need of the patient to receive information. Scores are categorized into preference for
either high, moderate, or low levels of information provision.
Clinical Decision Making Involvement and Satisfaction Scale (CDIS) (26).This
instrument measures involvement and satisfaction with a recently experienced clinical
decision, as rated by both patient and staff. The Involvement (CDIS-INV) subscale is assessed
through a single item rating the extent to which the decision was shared, passive or actively
made by the patient (rated on a 5-point scale). The Satisfaction (CDIS-SAT) subscale is
assessed by level of agreement on a 5-point Likert scale with six items regarding a) being
informed, b) making the best decision, c) consistency with personal values, d) expectation of
implementing the decision, e) whether this was the best decision to make, and f) overall
satisfaction. The satisfaction score is then classified into three categories: high, moderate and
low. CEDAR measures and scoring information can be downloaded at www.cedar-
net.eu/instruments.
Analysis
Data were analyzed using SPSS for Windows 23.0. Comparisons of service use, as
assessed by the CSSRI-EU, at baseline and follow-up were conducted using non-parametric
paired Wilcoxon rank tests, with Bonferroni adjustment for multiple analyses. Costs of inpatient
admissions at baseline and follow-up were assessed via paired t-tests. Predictors of baseline
service use were assessed via negative binomial regression analyses, entering all baseline
staff-rated and patient-rated subscales of the CDMS and CDIS as predictors, after controlling
for age, gender, marital status, study site, diagnosis and duration of illness. To assess
changes in service use over time, multilevel models were used with a random slope and
intercept; controlling for the same covariates.
Results
A total of 588 psychiatric outpatients from the six centers participated. Mean age of
participants was 41.7 years (SD = 10.7). The majority of participants were unmarried (n = 439,
75%), unemployed (n = 478, 81%) and female (n = 307, 52%). The most common DSM-IV
diagnoses were psychotic disorders (n = 269, 46%) and mood disorders (n = 200, 34%), and
the average duration of illness was 12.5 years (SD = 9.3). Each participant had an allocated staff
member. Paired data for the 588 patients were obtained from staff members (N = 213); with some staff
members providing data for multiple patients. Staff members had a mean age of 45.9 years (SD =
10.6) and 62% were female (n = 127). Of those participating, 37% were psychiatrists (n = 75), 9%
psychologists (n = 19), 5% social workers (n = 11), whilst 49% were from another profession within
mental health services (n = 100). On average, staff had worked in mental health for 15.0 years (SD =
9.7).
At baseline, the majority of both patients and staff expressed a preference on the CDMS-PD
for shared (71%, 54% respectively) rather than active (8%, 16%) or passive (22%, 30%) decision
making. The majority of patients reported a preference on the CDMS-IN for receiving high levels of
information regarding decisions, whereas the majority of staff preferred patients to receive a moderate
amount (high 61%, 35%; mod 35%, 57%; low 4%, 8%). When asked at baseline about the most
recently experienced clinical decision on the CDIS-INV, nearly half of all patients and staff reported
that the decision had been shared (50%, 47%; passive 27%, 23%; active 24%, 30%). The majority of
staff and patients reported being moderately or highly satisfied with the decision on the CDIS-SAT
(high 52%, 45%; mod 43%, 51%; low 6%, 4%).
Community contacts and day services were the most commonly used services at both
baseline and follow-up, with a total of 201 inpatient admissions across the sample at baseline and 137
by follow-up (see Table 1). Comparison of self-reported service use showed that number and length of
inpatient stays significantly decreased between baseline and follow-up. Likewise, total costs of
inpatient admissions significantly decreased from €2 512 330 at baseline to €807 803 at follow up (t =
3.82, df =519, p >.001). No significant changes were observed for the number of outpatient, day
service and community contacts, nor for number of medications prescribed.
##Table 1 about here##
Relationship between decision-making and baseline service use
At baseline, a patient-rated preference on the CDMS-PD for an active style was associated
with a higher number of inpatient stays than preferences for passive of shared style (see Table 2).
##Table 2 here ##
The duration and costs of such inpatient admissions were significantly predicted by all
subscales, both staff- and patient-rated. Patient-rated CDMS preferences for passive or
shared CDM style were associated with shorter admissions than preferences for active CDM
style and, relatedly, with lower costs compared with preferences for active CDM. On the staff-
rated CDMS-PD, a preference for shared CDM style predicted slightly longer admissions, and
preferences for a passive style were related to decreased costs. A preference for low levels of
information provision on the CDMS-IN (both staff- and patient-rated) predicted shorter
admissions and lower costs than high CDMS-IN. Similarly, both staff- and patient-reported
passive involvement in a recent decision on the CDIS-INV predicted fewer days of inpatient
admissions than active involvement, and passive and shared CDIS-INV predicted lower costs.
Patient-rated low satisfaction on the CDIS-SAT predicted an increased number of admission
days and increased costs, whereas a higher number of days and costs were associated with
moderate staff-rated satisfaction. The number of outpatient contacts, day services, community
contacts, and prescribed medications were not associated with the CDMS or CDIS subscales.
Relationship between decision-making and service use over time
Significant changes in service use were further examined to identify predictors thereof.
Number of inpatient admissions was significantly predicted by both patient- and staff-rated CDMS-PD.
An increase in the number of stays over time was predicted by patient preference for active decision
making (b = .236, t = 2.03, df= 353, p =.043) and a staff preference for shared decision making (b =
.181, t = 2.21, df= 353, p =.028). A longer length of inpatient stay was predicted by staff-rated
preference for shared decision making compared with a patient preference for a passive style (b =
5.49, t = 2.17, df= 706, p =.030). The change in costs over one year was predicted by the patient-rated
CDIS-SAT, with low satisfaction associated with an increase in costs (b = 4803, t = 2.83, df =752, p
=.005).
Discussion
This study contributes to the limited exploration of clinical decision making and its association
with mental health service use amongst people with SMI. Decision making preferences and
experiences were associated with number and duration of inpatient admissions and associated costs,
both at baseline and with changes over 12-months. Measures of decision making were, however,
unrelated to use of medications, and community, day and outpatient services.
Consistent with a growing body of evidence suggesting that, in medical settings, decision
making style may be associated with cost-effectiveness (7,8), the present findings also suggest that
aspects of decision making are related to service use and costs. Specifically, both preferences for and
experiences of passive and shared, as opposed to active, decision making were associated with
reduced hospital admissions and costs. Although reduced costs do not equate to cost-effectiveness,
such findings are in line with the observations from physical health settings (8) that shared decision
making might improve cost-effectiveness, possibly via improved treatment and thus a reduction in the
need for hospital admissions (4,7,8). This finding may also reflect shared factors that influence both
decision making and treatment outcomes. Those who are less unwell are more likely to express a
preference for shared decision making (1, 14) and, concomitantly, are less likely to have inpatient
admissions, especially lengthy ones. Additionally, it has previously been reported that patients’ belief
of their own decisional capacity influences CDM preferences (31). Thus, preferences for participation
in decision making and level of involvement in decisions may be a marker for other factors such as
insight, understanding about the illness, and illness severity, which are related to inpatient stays and
costs. Our results showed that those preferring and experiencing active CDM had more admissions,
thus active, as opposed to passive or shared CDM may be a marker for those who are less well. The
extent to which the relationship between decision making and admission costs is mediated by insight
and clinical presentation would be a beneficial avenue for future research. More rigorously designed
studies are needed to ascertain if decision making has a causal association with reducing admissions
and costs.
A low patient satisfaction with experienced decision making predicted longer admissions and
higher costs at baseline, as well as an increase in costs over time; highlighting the importance of
patient satisfaction with their experienced decisions. This finding is in line with earlier research
suggesting that patient satisfaction with explanations offered by service providers is associated with
service use in people with severe mental illness (29). Whether satisfaction with actual decision making
independently drives the association with costs and admissions, or whether dissatisfaction is
associated with poorer wellbeing and greater illness severity and therefore higher costs
remains unclear. Although evidence that decision making interventions improve satisfaction is
currently limited, this finding provides further support that the ongoing development of
strategies to maximize patient satisfaction with CDM experiences (e.g., 33,34) may be
beneficial in reducing admissions. Relatedly, the extent to which differential preferences of
patient and treating clinician impact upon experienced CDM, especially patient satisfaction,
would be a value avenue for future exploration. Given the relationship between satisfaction
and service use, staff awareness of patient preferences and expectations would likely be
valuable to assist in enhancing patient satisfaction.
The study lends support for the assertion that there is no relationship between
preferred and experienced CDM and medication use in outpatient mental health settings (18),
contrasting previous findings showing satisfaction is related to medication adherence (17).
Additionally, despite previous evidence suggesting that involvement in decision making might
increase engagement with community care services (16), in the present study, the use of
outpatient and community services was unrelated to CDM preferences and experiences.
Although engagement was not directly studied, outpatient service use may serve as a proxy
indicator of engagement. Thus our results suggest that decision making, at least in those with
SMI, may be largely unrelated to engagement with outpatient services. Such a finding may
reflect that other factors contribute more to engagement with services, or may also reflect that
those participating in the study and completing bimonthly questionnaires are already more
engaged.
Limitations
Some limitations are noted in the present study. Firstly, the majority of the sample
reported being highly satisfied with their experienced CDM and this might have limited the
range of findings regarding relationships between satisfaction and outcomes. Secondly, the
experienced involvement in decision making was assessed using a single item, possibly
limiting the conclusions that can be drawn with service use. Relatedly, the scales used were
developed and validated within the study sample. As such, the ability of the scales to
differentiate between CDM experiences and preferences across settings and patient groups
cannot be certain. Additionally, only costs associated with inpatient admissions were assessed.
Multivariate analyses controlled for a range of demographic and illness-related covariates, however,
models are not exhaustive and additional factors which could impact the relationship between decision
making and service use might have been overlooked.The sample examined was heterogeneous, with
mixed diagnoses and co-morbidities and patients were treated in different clinics by different clinicians.
The staff also came from a diversity of professional backgrounds. Whilst heterogeneity might limit the
conclusions that can be drawn about the relationship between CDM preferences and experiences and
service use, the real world nature of the study increases the generalizability of the findings and builds
on the recommendation for naturalistic CDM research (2,4).
Conclusions
Findings highlight that several aspects of decision making are associated with inpatient
service use, but not with use of other services. The extent to which decision making preferences and
experiences are a marker for wellbeing and insight, or independently drive the associations with
service use requires ongoing exploration. Clinicians should ensure patients are satisfied with their
experiences of decision making. Decision making interventions might be fruitful for enhancing
treatment provision and, ultimately cost-effectiveness, in mental health services.
References
1. Laugharne R, Priebe S: Trust, choice and power in mental health: a literature review. Social
Psychiatry and Psychiatric Epidemiology 41:843–852, 2006
2. Drake RE, Cimpean D, Torrey WC: Shared decision making in mental health: prospects for
personalized medicine. Dialogues in Clinical Neuroscience 11:455–463, 2009
3. van der Krieke, Lian, Emerencia AC, Boonstra N, et al: A web-based tool to support shared
decision making for people with a psychotic disorder: randomized controlled trial and process
evaluation. Journal of Medical Internet Research 15:e216, 2013
4. Salyers MP, Matthias MS, Fukui S, et al: A coding system to measure elements of shared
decision making during psychiatric visits. Psychiatric Services 63:779–784, 2012
5. Calsyn RJ, Winter JP, Morse GA: Do consumers who have a choice of treatment have better
outcomes? Community Mental Health Journal 36:149–160, 2000
6. Duncan E, Best C, Hagen S: Shared decision making interventions for people with mental health
conditions. The Cochrane database of systematic reviews:CD007297, 2010
7. Legare F, Witteman HO: Shared decision making: examining key elements and barriers to
adoption into routine clinical practice. Health Affairs 32:276–284, 2013
8. Veroff D, Marr A, Wennberg DE: Enhanced support for shared decision making reduced costs of
care for patients with preference-sensitive conditions. Health Affairs 32:285–293, 2013
9. Drake RE, Deegan PE, Rapp C: The promise of shared decision making in mental health.
Psychiatric Rehabilitation Journal 34:7–13, 2010
10. McCabe R, Priebe S: Communication and psychosis: it's good to talk, but how? The British
Journal of Psychiatry 192:404–405, 2008
11. Torrey WC, Drake RE: Practicing shared decision making in the outpatient psychiatric care of
adults with severe mental illnesses: redesigning care for the future. Community Mental Health
Journal 46:433–440, 2010
12. De las Cuevas, Carlos, Rivero A, Perestelo-Perez L, et al: Psychiatric patients' attitudes towards
concordance and shared decision making. Patient Education and Counseling 85:245–250, 2011
13. Woltmann EM, Whitley R: Shared decision making in public mental health care: perspectives from
consumers living with severe mental illness. Psychiatric Rehabilitation Journal 34:29–36, 2010
14. Hamann J, Cohen R, Leucht S, et al: Do patients with schizophrenia wish to be involved in
decisions about their medical treatment? The American Journal of Psychiatry 162:2382–2384,
2005
15. Edwards K: Service users and mental health nursing. Journal of Psychiatric and Mental Health
Nursing 7:555–565, 2000
16. Dwight-Johnson M, Unutzer J, Sherbourne C, et al: Can quality improvement programs for
depression in primary care address patient preferences for treatment? Medical Care 39:934–944,
2001
17. Mahone IH: Shared decision making and serious mental illness. Archives of Psychiatric Nursing
22:334–343, 2008
18. Stein BD, Kogan JN, Mihalyo MJ, et al: Use of a computerized medication shared decision
making tool in community mental health settings: impact on psychotropic medication adherence.
Community Mental Health Journal 49:185–192, 2013
19. Adams JR, Drake RE: Shared decision-making and evidence-based practice. Acta Psychiatrica
Scandinavica 42:87–105, 2006
20. Matthias MS, Salyers MP, Rollins AL, et al: Decision making in recovery-oriented mental health
care. Psychiatric Rehabilitation Journal 35:305–314, 2012
21. Puschner B, Steffen S, Slade M, et al: Clinical decision making and outcome in routine care for
people with severe mental illness (CEDAR): study protocol. BMC Psychiatry 10:90, 2010
22. First MB, Spitzer RL, Gibbon M, et al: Structured Clinical Interviews for DSM-IV Axis I Disorders -
Clinical Version (SCID-CV). Washington, DC, American Psychiatric Press, 1997
23. Möller HJ, Jäger M, Riedel M, et al: The Munich 15-year follow-up study (MUFSSAD) on first-
hospitalized patients with schizophrenic or affective disorders: assessing courses, types and time
stability of diagnostic classification. European Psychiatry 26:231–243, 2010
24. Slade M, Powell R, Rosen A, et al: Threshold Assessment Grid (TAG): the development of a valid
and brief scale to assess the severity of mental illness. Social Psychiatry and Psychiatric
Epidemiology 35:78–85, 2000
25. Chisholm D, Knapp MR, Knudsen HC, et al: Client Socio-Demographic and Service Receipt
Inventory--European Version: development of an instrument for international research. EPSILON
Study 5. European Psychiatric Services: Inputs Linked to Outcome Domains and Needs. The
British Journal of Psychiatry:s28-33, 2000
26. Slade M, Jordan H, Clarke E, et al: The development and evaluation of a five-language multi-
perspective standardised measure: clinical decision-making involvement and satisfaction (CDIS).
BMC Health Services Research 28:323, 2014
27. Puschner B, Neumann P, Jordan H, et al: Development and psychometric properties of a five-
language multiperspective instrument to assess clinical decision making style in the treatment of
people with severe mental illness (CDMS). BMC Psychiatry 13:48, 2013
28 Clarke E, Puschner B, Jordan H, Williams P, Konrad J, Kawohl W, Bär A, Rössler W, Del Vecchio
V, Sampogna G, Nagy M, Süveges A, Krogsgaard Bording M, Slade M Empowerment and
satisfaction in a multinational study of routine clinical practice, Acta Psychiatrica Scandinavica, in
press).
29. Jabbar F, Casey P, Schelten SL, et al: What do you think of us? Evaluating patient knowledge of
and satisfaction with a psychiatric outpatient service. Irish Journal of Medical Science 180:195–
201, 2011
29. Chewning B, Bylund CL, Shah B, Arora NK, Gueguen JA, Makoul G. Patient preferences for
shared decisions: a systematic review. Patient Educ Couns 2012; 86(1): 9-18; Duncan E, Best C,
Hagen S.
30. Decoux M: Acute versus primary care: the health care decision making process for individuals
with severe mental illness. Issues in Mental Health Nursing 26:935–951, 2005
31. Hamann J, Mendel R, Reiter S, et al: Why do some patients with schizophrenia want to be
engaged in medical decision making and others do not? The Journal of Clinical Psychiatry
72:1636–1643, 2011
32. Cummings SM, Cassie KM: Perceptions of biopsychosocial services needs among older adults
with severe mental illness: met and unmet needs. Health & Social Work 33:133–143, 2008
33. Hamann J, Mendel R, Meier A, et al: "How to speak to your psychiatrist": shared decision-making
training for inpatients with schizophrenia. Psychiatric Services 62:1218–1221, 2011
34. Woltmann EM, Wilkniss SM, Teachout A, et al: Trial of an Electronic Decision Support System to
Facilitate Shared Decision Making in Community Mental Health. Psychiatric Services 62:54–60,
2011
Table 1. Self-reported service use at baseline and 12-month follow up (N =578)
Baseline 12-month
follow up
Total Md IQR Total Md IQR Za P-valueb
Inpatient days (previous year) 6547 0.0 0.0-1.0 2871 0.0 0.0-0.0 -4.31 >.001
Inpatient stays (previous year) 201 0.0 0.0-1.0 137 0.0 0.0-0.0 -4.31 >.001
Outpatient visits (previous 3 months) 2716 1.0 1.0-6.0 3165 2.0 2.0-5.0 -0.27 .787
Day services (previous 3 months) 2683 0.0 0.0-1.0 2236 0.0 0.0-0.0 -1.74 .081
Community contacts (previous 3 months) 5769 5.0 1.0-14.0 5106 5.0 5.0-12.0 -2.42 .016
Psychotropic medications (previous month) 1555 2.0 2.0-4.0 1332 2.0 1.0-3.0 -2.25 .024
Notes: Md = median; IQR = interquartile range; aWilcoxon signed-rank test; b Bonferroni adjusted p = 0.05/6 = 0.008
Table 2: Predictors of inpatient stays, days and costs at baseline
Inpatient staysa Inpatient daysb Costs of inpatient daysc
b SE OR 95% CI b SE OR 95% CI b SE OR 95% CI
Patient-rated
CDMS PD passive^ -.929 .364 .395 .193 - .806 -1.45 .244 .235 .146 - .380 -2.74 .292 .064 .036 -.114
CDMS PD shared^ -.779 .291 .459 .260 - .812 -1.05 .203 .348 .234 - .519 -1.60 .228 .203 .130 - .317
CDMS IN low◊ -1.22 1.09 .294 .035 - 2.50 -3.17 .564 .042 .014 - .127 -5.87 .507 .003 .001 - .008
CDMS IN moderate◊ .054 .233 1.06 .668 - 1.67 .045 .140 1.05 .794 - 1.37 .551 .153 1.73 1.28 - 2.34
CDIS INV lowǂ -.112 .346 .894 .454 - 1.76 -.953 .211 .386 .255 - .583 -1.26 .227 .283 .182 - .441
CDIS INV moderateǂ -.124 .288 .884 .503 - 1.55 -.390 .177 .677 .478 - .959 -1.07 .187 .344 .238 - .496
CDIS SAT low§ .190 .453 .190 .453 - .190 1.39 .306 4.01 2.20 - 7.30 2.84 .337 17.1 8.85 - 33.1
CDIS SAT moderate§ -.118 .245 -.118 .245 - 1.18 -.194 .152 .824 .612 - 1.11 -.178 .157 .837 .616 - 1.14
Staff-rated
CDMS PD passive^ -.643 .462 .526 .213 - 1.30 -.362 .281 .697 .401 - 1.21 -1.36 .305 .258 .142 - .468
CDMS PD shared^ -.019 .374 .981 .471 - 2.04 .619 .246 1.86 1.15 - 3.01 -.105 .259 .901 .543 - 1.50
CDMS IN low◊ -.766 .583 .465 .148 - 1.46 -1.25 .286 .287 .164 - .502 -1.63 .297 .196 .110 - .351
CDMS IN moderate◊ -.017 .233 .983 .624 - 1.55 .136 .141 1.15 .868 - 1.51 1.49 .147 4.45 3.33 - 5.94
CDIS INV lowǂ -.606 .357 .546 .271 - 1.10 -1.03 .217 .357 .233 - .546 -2.88 .225 .056 .036 - .087
CDIS INV moderateǂ -.381 .267 .683 .405 - 1.15 -.297 .159 .743 .544 - 1.02 -.478 .149 .620 .463 - .830
CDIS SAT low§ -.219 .531 .803 .284 - 2.27 .178 .3318 1.20 .624 - 2.29 .001 .327 1.00 .528 - 1.90
CDIS SAT moderate§ .205 .226 1.23 .788 - 1.91 .592 .142 1.81 1.37- 2.39 1.59 .155 4.91 3.62 - 6.66
Notes: All models controlled for age, gender, marital status, illness duration, DSM IV disorder, and study site; a: χ2(23) = 57.6, p<.001; b: χ2(23) =
414.5, p<.001; c: χ2(22) = 1012, p<.001; ^ reference group= active CDM; ◊ reference group = high information; ǂ reference group= high
involvement; § reference group= high satisfaction.
